Genetic discovery and risk characterization in type 2 diabetes across diverse populations
Summary: Genomic discovery and characterization of risk loci for type 2 diabetes (T2D) have been conducted primarily in individuals of European ancestry. We conducted a multiethnic genome-wide association study of T2D among 53,102 cases and 193,679 control subjects from African, Hispanic, Asian, Nat...
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-04-01
|
Series: | HGG Advances |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666247721000105 |
id |
doaj-dbef0a520b5d4bda84a828de1df9808d |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Linda M. Polfus Burcu F. Darst Heather Highland Xin Sheng Maggie C.Y. Ng Jennifer E. Below Lauren Petty Stephanie Bien Xueling Sim Wei Wang Pierre Fontanillas Yesha Patel Michael Preuss Claudia Schurmann Zhaohui Du Yingchang Lu Suhn K. Rhie Joseph M. Mercader Teresa Tusie-Luna Clicerio González-Villalpando Lorena Orozco Cassandra N. Spracklen Brian E. Cade Richard A. Jensen Meng Sun Yoonjung Yoonie Joo Ping An Lisa R. Yanek Lawrence F. Bielak Salman Tajuddin Aude Nicolas Guanjie Chen Laura Raffield Xiuqing Guo Wei-Min Chen Girish N. Nadkarni Mariaelisa Graff Ran Tao James S. Pankow Martha Daviglus Qibin Qi Eric A. Boerwinkle Simin Liu Lawrence S. Phillips Ulrike Peters Chris Carlson Lynne R. Wikens Loic Le Marchand Kari E. North Steven Buyske Charles Kooperberg Ruth J.F. Loos Daniel O. Stram Christopher A. Haiman |
spellingShingle |
Linda M. Polfus Burcu F. Darst Heather Highland Xin Sheng Maggie C.Y. Ng Jennifer E. Below Lauren Petty Stephanie Bien Xueling Sim Wei Wang Pierre Fontanillas Yesha Patel Michael Preuss Claudia Schurmann Zhaohui Du Yingchang Lu Suhn K. Rhie Joseph M. Mercader Teresa Tusie-Luna Clicerio González-Villalpando Lorena Orozco Cassandra N. Spracklen Brian E. Cade Richard A. Jensen Meng Sun Yoonjung Yoonie Joo Ping An Lisa R. Yanek Lawrence F. Bielak Salman Tajuddin Aude Nicolas Guanjie Chen Laura Raffield Xiuqing Guo Wei-Min Chen Girish N. Nadkarni Mariaelisa Graff Ran Tao James S. Pankow Martha Daviglus Qibin Qi Eric A. Boerwinkle Simin Liu Lawrence S. Phillips Ulrike Peters Chris Carlson Lynne R. Wikens Loic Le Marchand Kari E. North Steven Buyske Charles Kooperberg Ruth J.F. Loos Daniel O. Stram Christopher A. Haiman Genetic discovery and risk characterization in type 2 diabetes across diverse populations HGG Advances Type 2 Diabetes Genetic Risk Score |
author_facet |
Linda M. Polfus Burcu F. Darst Heather Highland Xin Sheng Maggie C.Y. Ng Jennifer E. Below Lauren Petty Stephanie Bien Xueling Sim Wei Wang Pierre Fontanillas Yesha Patel Michael Preuss Claudia Schurmann Zhaohui Du Yingchang Lu Suhn K. Rhie Joseph M. Mercader Teresa Tusie-Luna Clicerio González-Villalpando Lorena Orozco Cassandra N. Spracklen Brian E. Cade Richard A. Jensen Meng Sun Yoonjung Yoonie Joo Ping An Lisa R. Yanek Lawrence F. Bielak Salman Tajuddin Aude Nicolas Guanjie Chen Laura Raffield Xiuqing Guo Wei-Min Chen Girish N. Nadkarni Mariaelisa Graff Ran Tao James S. Pankow Martha Daviglus Qibin Qi Eric A. Boerwinkle Simin Liu Lawrence S. Phillips Ulrike Peters Chris Carlson Lynne R. Wikens Loic Le Marchand Kari E. North Steven Buyske Charles Kooperberg Ruth J.F. Loos Daniel O. Stram Christopher A. Haiman |
author_sort |
Linda M. Polfus |
title |
Genetic discovery and risk characterization in type 2 diabetes across diverse populations |
title_short |
Genetic discovery and risk characterization in type 2 diabetes across diverse populations |
title_full |
Genetic discovery and risk characterization in type 2 diabetes across diverse populations |
title_fullStr |
Genetic discovery and risk characterization in type 2 diabetes across diverse populations |
title_full_unstemmed |
Genetic discovery and risk characterization in type 2 diabetes across diverse populations |
title_sort |
genetic discovery and risk characterization in type 2 diabetes across diverse populations |
publisher |
Elsevier |
series |
HGG Advances |
issn |
2666-2477 |
publishDate |
2021-04-01 |
description |
Summary: Genomic discovery and characterization of risk loci for type 2 diabetes (T2D) have been conducted primarily in individuals of European ancestry. We conducted a multiethnic genome-wide association study of T2D among 53,102 cases and 193,679 control subjects from African, Hispanic, Asian, Native Hawaiian, and European population groups in the Population Architecture Genomics and Epidemiology (PAGE) and Diabetes Genetics Replication and Meta-analysis (DIAGRAM) Consortia. In individuals of African ancestry, we discovered a risk variant in the TGFB1 gene (rs11466334, risk allele frequency (RAF) = 6.8%, odds ratio [OR] = 1.27, p = 2.06 × 10−8), which replicated in independent studies of African ancestry (p = 6.26 × 10−23). We identified a multiethnic risk variant in the BACE2 gene (rs13052926, RAF = 14.1%, OR = 1.08, p = 5.75 × 10−9), which also replicated in independent studies (p = 3.45 × 10−4). We also observed a significant difference in the performance of a multiethnic genetic risk score (GRS) across population groups (pheterogeneity = 3.85 × 10−20). Comparing individuals in the top GRS risk category (40%–60%), the OR was highest in Asians (OR = 3.08) and European (OR = 2.94) ancestry populations, followed by Hispanic (OR = 2.39), Native Hawaiian (OR = 2.02), and African ancestry (OR = 1.57) populations. These findings underscore the importance of genetic discovery and risk characterization in diverse populations and the urgent need to further increase representation of non-European ancestry individuals in genetics research to improve genetic-based risk prediction across populations. |
topic |
Type 2 Diabetes Genetic Risk Score |
url |
http://www.sciencedirect.com/science/article/pii/S2666247721000105 |
work_keys_str_mv |
AT lindampolfus geneticdiscoveryandriskcharacterizationintype2diabetesacrossdiversepopulations AT burcufdarst geneticdiscoveryandriskcharacterizationintype2diabetesacrossdiversepopulations AT heatherhighland geneticdiscoveryandriskcharacterizationintype2diabetesacrossdiversepopulations AT xinsheng geneticdiscoveryandriskcharacterizationintype2diabetesacrossdiversepopulations AT maggiecyng geneticdiscoveryandriskcharacterizationintype2diabetesacrossdiversepopulations AT jenniferebelow geneticdiscoveryandriskcharacterizationintype2diabetesacrossdiversepopulations AT laurenpetty geneticdiscoveryandriskcharacterizationintype2diabetesacrossdiversepopulations AT stephaniebien geneticdiscoveryandriskcharacterizationintype2diabetesacrossdiversepopulations AT xuelingsim geneticdiscoveryandriskcharacterizationintype2diabetesacrossdiversepopulations AT weiwang geneticdiscoveryandriskcharacterizationintype2diabetesacrossdiversepopulations AT pierrefontanillas geneticdiscoveryandriskcharacterizationintype2diabetesacrossdiversepopulations AT yeshapatel geneticdiscoveryandriskcharacterizationintype2diabetesacrossdiversepopulations AT michaelpreuss geneticdiscoveryandriskcharacterizationintype2diabetesacrossdiversepopulations AT claudiaschurmann geneticdiscoveryandriskcharacterizationintype2diabetesacrossdiversepopulations AT zhaohuidu geneticdiscoveryandriskcharacterizationintype2diabetesacrossdiversepopulations AT yingchanglu geneticdiscoveryandriskcharacterizationintype2diabetesacrossdiversepopulations AT suhnkrhie geneticdiscoveryandriskcharacterizationintype2diabetesacrossdiversepopulations AT josephmmercader geneticdiscoveryandriskcharacterizationintype2diabetesacrossdiversepopulations AT teresatusieluna geneticdiscoveryandriskcharacterizationintype2diabetesacrossdiversepopulations AT cliceriogonzalezvillalpando geneticdiscoveryandriskcharacterizationintype2diabetesacrossdiversepopulations AT lorenaorozco geneticdiscoveryandriskcharacterizationintype2diabetesacrossdiversepopulations AT cassandranspracklen geneticdiscoveryandriskcharacterizationintype2diabetesacrossdiversepopulations AT brianecade geneticdiscoveryandriskcharacterizationintype2diabetesacrossdiversepopulations AT richardajensen geneticdiscoveryandriskcharacterizationintype2diabetesacrossdiversepopulations AT mengsun geneticdiscoveryandriskcharacterizationintype2diabetesacrossdiversepopulations AT yoonjungyooniejoo geneticdiscoveryandriskcharacterizationintype2diabetesacrossdiversepopulations AT pingan geneticdiscoveryandriskcharacterizationintype2diabetesacrossdiversepopulations AT lisaryanek geneticdiscoveryandriskcharacterizationintype2diabetesacrossdiversepopulations AT lawrencefbielak geneticdiscoveryandriskcharacterizationintype2diabetesacrossdiversepopulations AT salmantajuddin geneticdiscoveryandriskcharacterizationintype2diabetesacrossdiversepopulations AT audenicolas geneticdiscoveryandriskcharacterizationintype2diabetesacrossdiversepopulations AT guanjiechen geneticdiscoveryandriskcharacterizationintype2diabetesacrossdiversepopulations AT lauraraffield geneticdiscoveryandriskcharacterizationintype2diabetesacrossdiversepopulations AT xiuqingguo geneticdiscoveryandriskcharacterizationintype2diabetesacrossdiversepopulations AT weiminchen geneticdiscoveryandriskcharacterizationintype2diabetesacrossdiversepopulations AT girishnnadkarni geneticdiscoveryandriskcharacterizationintype2diabetesacrossdiversepopulations AT mariaelisagraff geneticdiscoveryandriskcharacterizationintype2diabetesacrossdiversepopulations AT rantao geneticdiscoveryandriskcharacterizationintype2diabetesacrossdiversepopulations AT jamesspankow geneticdiscoveryandriskcharacterizationintype2diabetesacrossdiversepopulations AT marthadaviglus geneticdiscoveryandriskcharacterizationintype2diabetesacrossdiversepopulations AT qibinqi geneticdiscoveryandriskcharacterizationintype2diabetesacrossdiversepopulations AT ericaboerwinkle geneticdiscoveryandriskcharacterizationintype2diabetesacrossdiversepopulations AT siminliu geneticdiscoveryandriskcharacterizationintype2diabetesacrossdiversepopulations AT lawrencesphillips geneticdiscoveryandriskcharacterizationintype2diabetesacrossdiversepopulations AT ulrikepeters geneticdiscoveryandriskcharacterizationintype2diabetesacrossdiversepopulations AT chriscarlson geneticdiscoveryandriskcharacterizationintype2diabetesacrossdiversepopulations AT lynnerwikens geneticdiscoveryandriskcharacterizationintype2diabetesacrossdiversepopulations AT loiclemarchand geneticdiscoveryandriskcharacterizationintype2diabetesacrossdiversepopulations AT karienorth geneticdiscoveryandriskcharacterizationintype2diabetesacrossdiversepopulations AT stevenbuyske geneticdiscoveryandriskcharacterizationintype2diabetesacrossdiversepopulations AT charleskooperberg geneticdiscoveryandriskcharacterizationintype2diabetesacrossdiversepopulations AT ruthjfloos geneticdiscoveryandriskcharacterizationintype2diabetesacrossdiversepopulations AT danielostram geneticdiscoveryandriskcharacterizationintype2diabetesacrossdiversepopulations AT christopherahaiman geneticdiscoveryandriskcharacterizationintype2diabetesacrossdiversepopulations |
_version_ |
1721479870146412544 |
spelling |
doaj-dbef0a520b5d4bda84a828de1df9808d2021-05-04T07:33:10ZengElsevierHGG Advances2666-24772021-04-0122100029Genetic discovery and risk characterization in type 2 diabetes across diverse populationsLinda M. Polfus0Burcu F. Darst1Heather Highland2Xin Sheng3Maggie C.Y. Ng4Jennifer E. Below5Lauren Petty6Stephanie Bien7Xueling Sim8Wei Wang9Pierre Fontanillas10Yesha Patel11Michael Preuss12Claudia Schurmann13Zhaohui Du14Yingchang Lu15Suhn K. Rhie16Joseph M. Mercader17Teresa Tusie-Luna18Clicerio González-Villalpando19Lorena Orozco20Cassandra N. Spracklen21Brian E. Cade22Richard A. Jensen23Meng Sun24Yoonjung Yoonie Joo25Ping An26Lisa R. Yanek27Lawrence F. Bielak28Salman Tajuddin29Aude Nicolas30Guanjie Chen31Laura Raffield32Xiuqing Guo33Wei-Min Chen34Girish N. Nadkarni35Mariaelisa Graff36Ran Tao37James S. Pankow38Martha Daviglus39Qibin Qi40Eric A. Boerwinkle41Simin Liu42Lawrence S. Phillips43Ulrike Peters44Chris Carlson45Lynne R. Wikens46Loic Le Marchand47Kari E. North48Steven Buyske49Charles Kooperberg50Ruth J.F. Loos51Daniel O. Stram52Christopher A. Haiman53Department of Preventive Medicine, Center for Genetic Epidemiology, University of Southern California, Los Angeles, CA, USA; Corresponding authorDepartment of Preventive Medicine, Center for Genetic Epidemiology, University of Southern California, Los Angeles, CA, USADepartment of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USADepartment of Preventive Medicine, Center for Genetic Epidemiology, University of Southern California, Los Angeles, CA, USADivision of Genetic Medicine, Vanderbilt Genetics Institute, Vanderbilt University Medical Center, Nashville, TN, USAThe Vanderbilt Genetics Institute, Vanderbilt University Medical Center, Nashville, TN, USAThe Vanderbilt Genetics Institute, Vanderbilt University Medical Center, Nashville, TN, USAAdaptive Biotechnologies Corporation, Seattle, WA, USASaw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore, Singapore23andMe, Sunnyvale, CA, USA23andMe, Sunnyvale, CA, USADepartment of Preventive Medicine, Center for Genetic Epidemiology, University of Southern California, Los Angeles, CA, USAIcahn School of Medicine at Mount Sinai, The Charles Bronfman Institute for Personalized Medicine, New York, NY, USAIcahn School of Medicine at Mount Sinai, The Charles Bronfman Institute for Personalized Medicine, New York, NY, USADepartment of Preventive Medicine, Center for Genetic Epidemiology, University of Southern California, Los Angeles, CA, USADivision of Genetic Medicine, Vanderbilt Genetics Institute, Vanderbilt University Medical Center, Nashville, TN, USADepartment of Biochemistry and Molecular Medicine, University of Southern California, Los Angeles, CA, USAProgram in Metabolism, Broad Institute, Cambridge, MA, USAUnidad de Biología Molecular y Medicina Genómica, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Universidad Nacional Autónoma de Mexico, Mexico City, MexicoCentro de Estudios en Diabetes, Unidad de Investigacion en Diabetes y Riesgo Cardiovascular, Centro de Investigacion en Salud Poblacional, Instituto Nacional de Salud Pública, Mexico City, MexicoInstituto Nacional de Medicina Genómica, Mexico City, MexicoDepartment of Biostatistics and Epidemiology, University of Massachusetts, Amherst, MA, USADivision of Sleep and Circadian Disorders, Brigham and Women’s Hospital, Boston, MA, USACardiovascular Health Research Unit, Department of Medicine, University of Washington, Seattle, WA, USAWellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK, USADivision of Endocrinology, Metabolism, and Molecular Medicine, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USADivision of Statistical Genomics, School of Medicine, Washington University, St. Louis, MO, USADepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USADepartment of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, MI, USALaboratory of Epidemiology and Population Sciences, National Institute on Aging, National Institutes of Health, Baltimore, MD, USALaboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USACenter for Research on Genomics and Global Health, National Human Genome Institute, National Institutes of Health, Bethesda, MD, USADepartment of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USAInstitute for Translational Genomics and Population Sciences, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA, USADepartment of Public Health Sciences and Center for Public Health Genomics, University of Virginia School of Medicine, Charlottesville, VA, USAIcahn School of Medicine at Mount Sinai, The Charles Bronfman Institute for Personalized Medicine, New York, NY, USADepartment of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USADepartment of Biostatistics, Vanderbilt Genetics Institute, Vanderbilt University, Nashville, TN, USADivision of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis, MN, USAInstitute for Minority Health Research, University of Illinois Chicago, Chicago, IL, USACenter for Population Cohorts, Department of Epidemiology & Population Health, Albert Einstein College of Medicine, Bronx, NY, USAHuman Genetics Center, University of Texas Health Science Center, Houston, TX, USASchool of Public Health, Brown University, Providence, RI, USAAtlanta VA Medical Center, Decatur, GA, USA; Division of Endocrinology and Metabolism, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USADivision of Public Health Sciences, University of Washington, Department of Epidemiology, Fred Hutchinson Cancer Research Center, Seattle, WA, USADivision of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USAUniversity of Hawaii Cancer Center, University of Hawaii at Manoa, Honolulu, HI, USAUniversity of Hawaii Cancer Center, University of Hawaii at Manoa, Honolulu, HI, USADepartment of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USADepartment of Statistics, Rutgers University, Piscataway, NJ, USADivision of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USAIcahn School of Medicine at Mount Sinai, The Mindich Child Health and Development Institute, The Charles Bronfman Institute for Personalized Medicine, New York, NY, USADepartment of Preventive Medicine, Center for Genetic Epidemiology, University of Southern California, Los Angeles, CA, USADepartment of Preventive Medicine, Center for Genetic Epidemiology, University of Southern California, Los Angeles, CA, USA; Corresponding authorSummary: Genomic discovery and characterization of risk loci for type 2 diabetes (T2D) have been conducted primarily in individuals of European ancestry. We conducted a multiethnic genome-wide association study of T2D among 53,102 cases and 193,679 control subjects from African, Hispanic, Asian, Native Hawaiian, and European population groups in the Population Architecture Genomics and Epidemiology (PAGE) and Diabetes Genetics Replication and Meta-analysis (DIAGRAM) Consortia. In individuals of African ancestry, we discovered a risk variant in the TGFB1 gene (rs11466334, risk allele frequency (RAF) = 6.8%, odds ratio [OR] = 1.27, p = 2.06 × 10−8), which replicated in independent studies of African ancestry (p = 6.26 × 10−23). We identified a multiethnic risk variant in the BACE2 gene (rs13052926, RAF = 14.1%, OR = 1.08, p = 5.75 × 10−9), which also replicated in independent studies (p = 3.45 × 10−4). We also observed a significant difference in the performance of a multiethnic genetic risk score (GRS) across population groups (pheterogeneity = 3.85 × 10−20). Comparing individuals in the top GRS risk category (40%–60%), the OR was highest in Asians (OR = 3.08) and European (OR = 2.94) ancestry populations, followed by Hispanic (OR = 2.39), Native Hawaiian (OR = 2.02), and African ancestry (OR = 1.57) populations. These findings underscore the importance of genetic discovery and risk characterization in diverse populations and the urgent need to further increase representation of non-European ancestry individuals in genetics research to improve genetic-based risk prediction across populations.http://www.sciencedirect.com/science/article/pii/S2666247721000105Type 2 DiabetesGenetic Risk Score |